This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bdev:fda [2020/11/25 19:05] richard |
bdev:fda [2021/08/16 22:22] (current) |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== FDA approval ====== | ====== FDA approval ====== | ||
- | |||
Hi Richard, | Hi Richard, | ||
+ | |||
+ | |||
+ | |||
+ | FDA response {{ : | ||
+ | |||
+ | |||
+ | FDA submission, [[https:// | ||
+ | |||
+ | |||
You should complete a full validation of the instrument with a SARS-CoV-2 assay . | You should complete a full validation of the instrument with a SARS-CoV-2 assay . | ||
Line 76: | Line 84: | ||
Here is the partially filled template [[https:// | Here is the partially filled template [[https:// | ||
+ | |||
+ | |||
+ | |||
+ | ---- | ||
+ | |||
+ | |||
+ | If this is for over the counter, this is the correct template Template for Manufacturers of Molecular and Antigen Diagnostic COVID-19 Tests for Non-Laboratory Use (July 29, 2020), however within this template it refers to the other templates for specific studies. | ||
+ | |||
+ | |||
+ | In your PEUA package, the template (MS word document) outlining the following information about your specific device; including: | ||
+ | |||
+ | * A detailed description of your device | ||
+ | * The proposed Intended Use/ | ||
+ | * Protocols for any analytical, non-clinical, | ||
+ | * Description and results of all analytical, non-clinical, | ||
+ | * [Other information FDA would like to see – specific to this type of medical device product] | ||
+ | * Specific questions you would like addressed. | ||
+ | |||
+ | | ||
+ | |||
+ | |||
+ | |||
+ | |||